Pseudovirus News and Research

RSS
Single-dose adenovirus-vectored vaccine protects mice against SARS-CoV-2

Single-dose adenovirus-vectored vaccine protects mice against SARS-CoV-2

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Coronacept - A trap-and-destroy molecule against SARS-CoV-2

Coronacept - A trap-and-destroy molecule against SARS-CoV-2

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Membrane nanoparticles acts as a bait to trap SARS-CoV-2

Membrane nanoparticles acts as a bait to trap SARS-CoV-2

C-type lectin receptors play a role in SARS-CoV-2 infection

C-type lectin receptors play a role in SARS-CoV-2 infection

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Compelling study shows heparin may protect against COVID-19

Compelling study shows heparin may protect against COVID-19

Moderna vaccine induces robust immune response against SARS-CoV-2

Moderna vaccine induces robust immune response against SARS-CoV-2

Novel antibody test for SARS-CoV-2

Novel antibody test for SARS-CoV-2

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

Effective neutralization of SARS-CoV-2 by synthetic nanobodies targeting the spike protein

Effective neutralization of SARS-CoV-2 by synthetic nanobodies targeting the spike protein

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

SARS-CoV-2 mutated spike proteins show variations in cell entry

SARS-CoV-2 mutated spike proteins show variations in cell entry

SARS-CoV-2 mutation reduces S1 shedding, increases infective potential

SARS-CoV-2 mutation reduces S1 shedding, increases infective potential